MarketPeel
Insider Trading Intelligence
WQ

William P. Quinn

BOLT
CHIEF FINANCIAL OFFICER · BOLT BIOTHERAPEUTICS, INC. · CIK 0001724190
FILING MIX · LIFETIME77%/23%
BUYS
27
SELLS
8
TOTAL VALUE
$83.4K
COMPANIES
1
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
20,000
AVG SELL PX
TRADE KIND
SHOWING 35 / 35
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by William P. Quinn, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+30.00%-1.17%+1.05%-2.22%-2.36%
14d10+40.00%-2.76%+0.48%-3.24%-3.68%
30d10+40.00%-0.75%+2.10%-2.85%-9.38%
60d10+20.00%-12.84%+2.89%-15.73%-21.02%
90d10+30.00%-12.43%+2.92%-15.35%-20.68%
180d10+0.00%-38.13%+6.71%-44.85%-43.09%
1y10+0.00%-58.82%+13.38%-72.20%-72.22%
2y10(2 pending)+0.00%-79.86%+25.27%-105.13%-106.27%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BOLT · 20,000 shares · as of Jan 28, 2026
0175,000350,000525,000700,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 27 buys / 8 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000Jan 28, 2026Feb 4, 2026View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,6147,614Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,99921,999Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
12,4990Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
3,9270Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,9273,927Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
7,6140Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,74911,749Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,49912,499Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
11,7490Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,99934,999Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,49910,499Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
10,4990Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
5,0000Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
34,9990Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
President, CEO and CFO
21,9990Dec 12, 2025Dec 16, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
President, CEO and CFO
125$4.61$5762,313Dec 5, 2025Feb 4, 2026View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00042,188Oct 22, 2025Oct 24, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
President, CEO and CFO
125$5.49$6872,188Jun 6, 2025Oct 24, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
700,000700,000May 1, 2025May 1, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
President, CEO and CFO
2,500$0.50$1.2K41,272Dec 16, 2024May 1, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
440,000440,000Jul 23, 2024Jul 24, 2024View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
President, CEO and CFO
2,500$0.64$1.6K38,772Jun 6, 2024May 1, 2025View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
235,000235,000Mar 4, 2024Mar 6, 2024View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
7,500$0.95$7.1K36,272Dec 12, 2023Dec 13, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,500$0.78$2.0K28,772Dec 6, 2023Dec 13, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
1,829$1.18$2.2K26,272Jun 6, 2023Dec 13, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Feb 27, 2023Feb 28, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
210,000210,000Feb 18, 2022Feb 23, 2022View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
5,000$4.72$23.6K20,154Dec 8, 2021Dec 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
35$4.64$16215,154Dec 6, 2021Dec 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
1,221$16.65$20.3K15,119Jun 4, 2021Dec 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
1,200$20.00$24.0K13,898Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Feb 4, 2021Feb 8, 2021View →
Other insiders · BOLT
Loading peer insiders…
About this filer
CIK 0001724190
ROLE
Chief Financial Officer
PRIMARY
BOLT
COMPANIES
1
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001724190DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback